ShareThis Page

Company owned by former Steelers QB Batch develops tech for knee injuries

| Thursday, Jan. 28, 2016, 10:33 p.m.

A company established partly by former Steelers quarterback Charlie Batch soon will start making technology developed at the University of Pittsburgh to diagnose and monitor knee injuries, Pitt officials said Thursday.

The company, called Impellia, completed the first of three licenses for technology to prevent injuries and help athletes on the mend, according to a Pitt statement.

The first licensed product is called PIVOT, a software platform developed by researchers at UPMC Sports Medicine. It will help doctors diagnose injuries of the anterior cruciate ligament, or ACL, a tear in one of the knee ligaments.

PIVOT can be used as a diagnostic tool before surgery and during the rehabilitation process to monitor patients, officials said.

“We are thrilled that our PIVOT technology will be made widely available to doctors, physical therapists and athletic trainers,” said Volker Musahl, medical director of the UPMC Rooney Sports Complex and associate professor at the Pitt School of Medicine. “As both a clinician and a researcher, it is gratifying to know that our work will benefit not only elite athletes but also the general population.”

Batch could not be reached for comment.

“Through our team's growth-oriented approach, extensive domain expertise, and sales network, we have the means to build a broad platform for the technology,” he said in a statement.

Impellia plans to announce license agreements for two other products in coming weeks.

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.